Aim: To use an in vivo colonized wound model to quantify the effect of a new enhanced antimicrobial Hydrofiber dressing (AAA) on bioburden levels and wound healing rates.
Aim: Timely resolution of chronic diabetic foot ulcers (DFUs) will have a positive impact on the diabetic patient’s quality of life, and will have significant impact on costs associated w...
Aim: The development of bioburden in chronic, non-healing wounds is now acknowledged to be a precursor to wound infection and a cause of delayed healing. A new enhanced antimicrobial silv...
Aim: To examine patient case studies where challenging, non-healing wounds, that had previously been treated with standard silver dressings, iodine dressings, or antibiotics, were switche...